Hitachi Medical Systems formally launched its 1.2T vertical field open MR scanner at the RSNA meeting. Oasis, shown as a work-in-progress at last year’s meeting, cleared the FDA in September.
Hitachi Medical Systems formally launched its 1.2T vertical field open MR scanner at the RSNA meeting. Oasis, shown as a work-in-progress at last year's meeting, cleared the FDA in September. Built around a gradient system with 33 mT/m amplitude and 100 T/m/sec slew rate, the scanner features Zenith RF coils. These coils are the culmination of 20 years' experience in the development of vertical field MR, according to Hitachi. Field uniformity is driven by the company's proprietary Higher-Order Active Shim Technology, which is designed to ensure fat saturation over the scanner's large field-of-view. Oasis also features Hitachi's RAPID parallel imaging, TRAQ time-resolved MR angiography, and RADAR patient-motion compensating technology.
Hitachi is also unveiling a new pulse sequence for the cylindrical 1.5T Echelon scanner. The TIGRE sequence supports dynamic abdominal and bilateral breast studies at high temporal and spatial resolution.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
New Research Highlights Emerging MRI Contrast Agent for Bladder Imaging
August 21st 2024A new MRI contrast agent may provide a viable non-invasive alternative for the detection of interstitial cystitis, according to preliminary research presented at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan.
MRI Study Offers Insights on Traumatic Brain Injury and Cerebral Microbleeds
August 19th 2024Detecting cerebral microbleed (CMB) in one of six healthy adults in a new study, researchers also found that CMB was the only MRI marker of small vessel disease (SVD) to be significantly associated with traumatic brain injury (TBI).